MORGAN STANLEY - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 106 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2022. The put-call ratio across all filers is 12.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q2 2023$18,081
-89.4%
22,322
-90.9%
0.00%
Q1 2023$171,319
-5.8%
244,741
-5.0%
0.00%
Q4 2022$181,788
+218.9%
257,489
+598.9%
0.00%
Q3 2022$57,000
-31.3%
36,843
-56.0%
0.00%
Q2 2022$83,000
-66.5%
83,748
-51.4%
0.00%
Q1 2022$248,000
-68.2%
172,328
+15.5%
0.00%
Q4 2021$780,000
+245.1%
149,266
+286.0%
0.00%
Q3 2021$226,000
-47.7%
38,666
-28.0%
0.00%
Q2 2021$432,000
-14.1%
53,716
-11.2%
0.00%
Q1 2021$503,000
-58.3%
60,525
-62.0%
0.00%
Q4 2020$1,207,000
-71.5%
159,167
-59.9%
0.00%
-100.0%
Q3 2020$4,233,000
-62.3%
397,125
-46.4%
0.00%
-50.0%
Q2 2020$11,229,000
+324.9%
740,687
+133.5%
0.00%
+100.0%
Q1 2020$2,643,000
-70.8%
317,203
-40.8%
0.00%
-50.0%
Q4 2019$9,060,000
-13.7%
536,129
-5.2%
0.00%
-33.3%
Q3 2019$10,499,000
-0.6%
565,415
+22.5%
0.00%0.0%
Q2 2019$10,558,000
+5.5%
461,442
-3.1%
0.00%0.0%
Q1 2019$10,010,000
+423.5%
476,232
+186.5%
0.00%
+200.0%
Q4 2018$1,912,000
-55.6%
166,201
-11.5%
0.00%0.0%
Q3 2018$4,311,000
-15.3%
187,799
-17.7%
0.00%0.0%
Q2 2018$5,089,000
-20.0%
228,227
-18.0%
0.00%
-50.0%
Q1 2018$6,363,000
-5.0%
278,490
+9.0%
0.00%0.0%
Q4 2017$6,696,000
+119.0%
255,571
+87.8%
0.00%
+100.0%
Q3 2017$3,057,000
-13.2%
136,118
+5.8%
0.00%0.0%
Q2 2017$3,520,000
-37.1%
128,715
-44.4%
0.00%0.0%
Q1 2017$5,598,000
+9.2%
231,370
-6.3%
0.00%0.0%
Q4 2016$5,126,000
+243.1%
247,024
+350.7%
0.00%0.0%
Q3 2016$1,494,000
+100.5%
54,805
+5.9%
0.00%
Q2 2016$745,000
-11.7%
51,767
-11.9%
0.00%
Q1 2016$844,000
+3.7%
58,733
+55.3%
0.00%
Q4 2015$814,000
+4.6%
37,830
-21.4%
0.00%
Q3 2015$778,000
-33.4%
48,103
+6.3%
0.00%
Q2 2015$1,168,000
-13.8%
45,242
-24.9%
0.00%
Q1 2015$1,355,000
+8.7%
60,212
-7.3%
0.00%
Q4 2014$1,247,000
+40.7%
64,963
+57.8%
0.00%
Q3 2014$886,000
+5.7%
41,173
+27.8%
0.00%
Q2 2014$838,000
+56.6%
32,217
+31.1%
0.00%
Q1 2014$535,000
+91.8%
24,569
+7.6%
0.00%
Q4 2013$279,000
-2.8%
22,842
+6.6%
0.00%
Q3 2013$287,000
-37.2%
21,425
-61.9%
0.00%
Q2 2013$457,00056,2330.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 2,213,326$18,386,00010.92%
ORACLE INVESTMENT MANAGEMENT INC 3,776,121$31,417,0004.70%
GRIFFIN ASSET MANAGEMENT, INC. 1,358,644$11,304,0001.44%
Selkirk Management LLC 288,805$2,403,0000.72%
Chicago Capital, LLC 1,593,126$13,255,0000.56%
Cannell & Co. 1,097,419$9,131,0000.29%
TCI Wealth Advisors, Inc. 55,586$462,0000.20%
Belpointe Asset Management LLC 197,853$1,646,0000.14%
ALGERT GLOBAL LLC 29,580$246,0000.08%
THOMPSON INVESTMENT MANAGEMENT, INC. 60,900$507,0000.08%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders